Anti-interleukin-5 therapy in patients with severe asthma: from clinical trials to clinical practice. Beasley, R., Harper, J., & Masoli, M. The Lancet Respiratory Medicine, 8(5):425–427, May, 2020.
Anti-interleukin-5 therapy in patients with severe asthma: from clinical trials to clinical practice [link]Paper  doi  bibtex   
@article{beasley_anti-interleukin-5_2020,
	title = {Anti-interleukin-5 therapy in patients with severe asthma: from clinical trials to clinical practice},
	volume = {8},
	issn = {22132600},
	shorttitle = {Anti-interleukin-5 therapy in patients with severe asthma},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S2213260020300515},
	doi = {10.1016/S2213-2600(20)30051-5},
	language = {en},
	number = {5},
	urldate = {2021-05-07},
	journal = {The Lancet Respiratory Medicine},
	author = {Beasley, Richard and Harper, James and Masoli, Matthew},
	month = may,
	year = {2020},
	pages = {425--427},
}

Downloads: 0